Evaluation of the Diagnostic and Prognostic Value of Immunohistochemical Markers in Precancerous Lesions of the Cervix

ConditionCervix Cancer

Trial statusNot yet recruiting

Trial phaseNot applicable

Trial typeInterventional

Biological sexFemale

Age18+

SponsorIRCCS Azienda Ospedaliero-Universitaria di Bologna

About this trial

The study aims to evaluate the expression of certain proteins and their diagnostic and prognostic value in precancerous lesions of the cervix.

Eligibility criteria

Qualifiers

Patients with a diagnosis of CIN/SIL undergoing cervical biopsy/concussion whose tissue sample is archived at the Operative Unit of Pathological Anatomy and Histology

Obtaining written informed consent for the use of biological samples

Patients aged 18 years and over

Disqualifiers

None

Trial design

Treatments tested in this trial

Tissue, diagnostic and prognostic accuracy

Treatment groups

100 Participants

are divided into 1 treatment group

Sponsors and collaborators

IRCCS Azienda Ospedaliero-Universitaria di Bologna

Lead sponsor

Source ClinicalTrials.gov